Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS 2023-01-20 02:00
Hepagene Therapeutics Reports Positive Top-line Results for Phase 2a RISE Study of FXR Agonist HPG1860 in Patients with NASH 2023-01-19 23:00
Tigermed Completes Acquisition of Marti Farm 2023-01-19 14:59
China's First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List 2023-01-19 11:45
Keymed Biosciences | The Latest Results from the Phase Ia Clinical Study of CMG901 was presented at the 2023 ASCO GI CANCERS SYMPOSIUM 2023-01-18 09:52
IASO Bio Raises Nearly $75 Million in Series C1 Funding 2023-01-18 08:00
Asieris Appoints Dr. Linda Wu as Chief Development Officer 2023-01-18 07:00
Tanso Biosciences Expands Its Line-up with 250 Mouse GPCRs 2023-01-18 00:00
FDA Accepts GMP Plasmid DMF of OBiO Technology 2023-01-17 08:00
FAPON presents at 41st Annual J.P. Morgan Healthcare Conference 2023-01-16 22:09
CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China 2023-01-16 18:00
SD Biosensor Successfully Finishes JP Morgan Healthcare Conference 2023-01-13 15:11
DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS 2023-01-12 17:00
iNtRON is finalizing the SAL200 Tech Transfer 2023-01-12 09:34
Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future 2023-01-11 08:01
Dizal Announces China CDE Acceptance of New Drug Application for Sunvozertinib for Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations 2023-01-10 17:03
FAPON to attend 41st Annual J.P. Morgan Healthcare Conference 2023-01-10 16:37
SK Biopharmaceuticals to Present Future Plan for Global Investors, Partners at 'SK Bio Night' 2023-01-10 07:00
SK Inc. hosts "SK Bio Night" in San Francisco to expand global partnerships 2023-01-10 07:00
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy 2023-01-09 23:25
1 60 61 62 63 64 220